Explore the paradox of generic drug shortages: why increased competition leads to fragile supply chains. Learn about the economic pressures, regulatory hurdles, and the optimal number of manufacturers needed for stability.
VIEW MOREExplore the systemic causes of generic drug shortages, from manufacturing failures and API concentration in China and India to the economic pressures of PBMs.
VIEW MORE